Methotrexate Recruiting Phase 4 Trials for Ophthalmopathy, Thyroid-Associated Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02378298Rituximab (RTX) Therapy in Patients With Active TAO